ICTCAR-051

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameICTCAR-051
Drug Alias Namesecond generation anti-TSHR CAR T-cell therapy (Innovative Cellular Therapeutics)ICTCAR-051
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionThyroid stimulating hormone receptor modulators
TargetsThyroid stimulating hormone receptor
Therapy Area/IndicationsSolid tumoursThyroid Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnovative Cellular Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnovative Cellular Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursThyroid Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A